Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plinabulin and Pembrolizumab with Chemo for First-Line ES-SCLC
NCT05745350Phase 2Recruiting
- Start
- Mar 2024
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plinabulin in small cell lung cancer (SCLC). Started Mar 2024; status: recruiting.
02
Drugs
plinabulin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT05745350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05745350.